Early CT features and temporal lung changes in COVID-19 pneumonia in Wuhan, China.


Journal

European journal of radiology
ISSN: 1872-7727
Titre abrégé: Eur J Radiol
Pays: Ireland
ID NLM: 8106411

Informations de publication

Date de publication:
Jul 2020
Historique:
received: 08 03 2020
revised: 08 04 2020
accepted: 10 04 2020
pubmed: 11 5 2020
medline: 1 7 2020
entrez: 11 5 2020
Statut: ppublish

Résumé

To analyse the high-resolution computed tomography (HRCT) early imaging features and the changing trend of coronavirus disease 2019 (COVID-19) pneumonia. Forty-six patients with COVID-19 pneumonia who had an isolated lesion on the first positive CT were enrolled in this study. The following parameters were recorded for each lesion: sites, sizes, location (peripheral or central), attenuation (ground-glass opacity or consolidation), and other abnormalities (supply pulmonary artery dilation, air bronchogram, interstitial thickening, etc.). The follow-up CT images were compared with the previous CT scans, and the development of the lesions was evaluated. The lesions tended to be peripheral and subpleural. All the lesions exhibited ground-glass opacity with or without consolidation. A higher proportion of supply pulmonary artery dilation (89.13 % [41/46]) and air bronchogram (69.57 % [32/46]) were found. Other findings included thickening of the intralobular interstitium and a halo sign of ground glass around a solid nodule. Cavitation, calcification or lymphadelopathy were not observed. The reticular patterns were noted from the 14 days after symptoms onset in 7 of 20 patients (45 %). At 22-31 days, the lesions were completely absorbed only in 2 of 7 patients (28.57 %). The typical early CT features of COVID-19 pneumonia are ground-glass opacity, and located peripheral or subpleural location, and with supply pulmonary artery dilation. Reticulation was evident after the 2nd week and persisted in half of patients evaluated in 4 weeks after the onset. Long-term follow-up is required to determine whether the reticulation represents irreversible fibrosis.

Identifiants

pubmed: 32387924
pii: S0720-048X(20)30206-0
doi: 10.1016/j.ejrad.2020.109017
pmc: PMC7166310
pii:
doi:

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Pagination

109017

Informations de copyright

Copyright © 2020 Elsevier B.V. All rights reserved.

Déclaration de conflit d'intérêts

Declaration of Competing Interest All authors declare no relationships with any companies whose products or services may be related to the subject matter of the article.

Références

Immunol Res. 2014 Aug;59(1-3):118-28
pubmed: 24845462
N Engl J Med. 2020 Mar 26;382(13):1199-1207
pubmed: 31995857
Radiology. 2020 Apr;295(1):202-207
pubmed: 32017661
N Engl J Med. 2020 Feb 20;382(8):727-733
pubmed: 31978945
Radiology. 2003 Sep;228(3):810-5
pubmed: 12805557
Radiology. 2020 Apr;295(1):16-17
pubmed: 32017662
Am J Respir Crit Care Med. 2020 Feb 15;201(4):P7-P8
pubmed: 32004066
Radiology. 2020 Apr;295(1):18
pubmed: 32003646
Lancet. 2020 Feb 15;395(10223):497-506
pubmed: 31986264
Radiology. 2008 Mar;246(3):697-722
pubmed: 18195376
Lancet. 2020 Feb 15;395(10223):507-513
pubmed: 32007143
Eur Radiol. 2020 Jun;30(6):3306-3309
pubmed: 32055945

Auteurs

Qiongjie Hu (Q)

Department of Radiology, Tongji Hospital, Tongji Medical College, Huazhong University of Science and Technology, Jiefang Dadao 1095(#), Wuhan 430030, PR China.

Hanxiong Guan (H)

Department of Radiology, Tongji Hospital, Tongji Medical College, Huazhong University of Science and Technology, Jiefang Dadao 1095(#), Wuhan 430030, PR China.

Ziyan Sun (Z)

Department of Radiology, Tongji Hospital, Tongji Medical College, Huazhong University of Science and Technology, Jiefang Dadao 1095(#), Wuhan 430030, PR China.

Lu Huang (L)

Department of Radiology, Tongji Hospital, Tongji Medical College, Huazhong University of Science and Technology, Jiefang Dadao 1095(#), Wuhan 430030, PR China.

Chong Chen (C)

Department of Radiology, Tongji Hospital, Tongji Medical College, Huazhong University of Science and Technology, Jiefang Dadao 1095(#), Wuhan 430030, PR China.

Tao Ai (T)

Department of Radiology, Tongji Hospital, Tongji Medical College, Huazhong University of Science and Technology, Jiefang Dadao 1095(#), Wuhan 430030, PR China.

Yueying Pan (Y)

Department of Radiology, Tongji Hospital, Tongji Medical College, Huazhong University of Science and Technology, Jiefang Dadao 1095(#), Wuhan 430030, PR China. Electronic address: xpyy02@sina.com.

Liming Xia (L)

Department of Radiology, Tongji Hospital, Tongji Medical College, Huazhong University of Science and Technology, Jiefang Dadao 1095(#), Wuhan 430030, PR China. Electronic address: xialiming2017@outlook.com.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH